GIS vs NEUP · P/E 8.2, rev $18.42B vs rev $15.7M
General Mills Inc (GIS) versus Neuphoria Therapeutics Inc (NEUP) — a side-by-side from cached financials, not a winner call.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
Neuphoria Therapeutics Inc (NEUP) is a biotechnology company listed on NASDAQ.
Latest reported GIS revenue for 2026-05-31 was $18.42B. Net income was -$87.6M. Revenue was up 304.4% from 2025-05-25 to 2026-05-31. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
Latest reported NEUP revenue for 2025-03-31 was $15.7M. Net income was $8.5M. NEUP currently screens at market cap $23.6M.
GIS currently screens at market cap $17.80B and trailing P/E 8.2. NEUP currently screens at market cap $23.6M.
Not investment advice. Open the GIS and NEUP stock pages for the full models.
Not investment advice.